Best International Ambassador Award-Finalist, Pfizer and Pfizer Foundation
Pfizer’s Global Health Partnerships (GHP) combines the philanthropic and in-kind resources of the Pfizer Foundation and Pfizer Inc to combat the chronic disease epidemic by funding 31 non-profits worldwide.
The fight against noncommunicable diseases (NCDs) and their risk factors, such as tobacco use, have largely been neglected in overseas development aid to low and middle income countries.
Only 2% of the over $44 billion in aid have been devoted to fighting these diseases in the developing world. Pfizer Inc. and the Pfizer Foundation recognize this gap and through GHP invested $47 million over four years in promising cancer and tobacco-control partner organizations operating in 46 countries.
Focus areas include:
- Helping Smokers Quit
- Building the Evidence for Enhancing Care
- Screening To Save Lives and,
- Navigating Cancer Patients Through Complicated Health
- Care Systems
After Pfizer’s four year investment, strong results are seen, including:
- Developing model programs that have received attention from health ministers, including innovative healthcare professional trainings for tobacco cessation, development of cancer registries and quit-lines, public awareness screening campaigns and smoke-free workplace programs.
- Contributing to smoke-free laws in Brazil, China, Mexico, and the Philippines.
The Overall Strategy
Pfizer is leveraging its resources and expertise to address the world’s health challenges of which cancer is one. The company recognizes that only by partnering with those who share a vision of a healthier world can it be a catalyst for change and help to toward eradicate this disease.
GHP worked with Pfizer’s local markets to identify leading organizations addressing cancer and tobacco control. Grantees were nominated by local offices and selected through a competitive process.
In Turkey cancer surveillance data and lack of a national cancer registry kept health officials and advocates unaware of the extent of Turkey’s cancer burden. The Pfizer’s grantee, New Hope in Health, is addressing Turkey’s data limitations by improving the national capacity to collect high quality cancer registry data and to use this information to rally advocacy groups.
Subsequently, cancer registration has become a governmental priority of Turkey’s Ministry of Health. Partnering with New Hope, the Ministry will be increasing the number and quality of cancer registration centers in order to obtain data for all of Turkey. To date, the program has established a total of 10 registry centers by training more than 40 cancer registrars in the principles of registry and geographic information systems.
Pfizer Foundation’s investment includes providing technical assistance in areas of monitoring and evaluation from the Johns Hopkins Bloomberg School of Public Health. Partners have learned how to improve their ongoing prevention and control efforts and how to develop an evidence base on which to continue these efforts and advocate for national-level change.
The United Nations meeting on NCDs this September addressed the crisis and the resulting socioeconomic and developmental challenges facing low- and middle-income countries.
Dialogue around, and recommendations for, this summit largely centered on the role of governments and their ministries of health in combating noncommunicable.